Mario Campone | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts (journal article) Nocquet, Lisa \| Roul, Julie \| Lefebvre, Chloé C. \| Duarte, Laurine \| Campone, Mario \| Juin, Philippe P. \| Souazé, Frédérique Scientific Reports, volume 14, issue 1 (2024). 10.1038/s41598-024-64696-z Cite \| Source
Prediction of pathological response to neo-adjuvant chemotherapy using texture parameters of initial 18-FDG PET/CT in estrogen receptor positive/Her2 negative (ER+/HER2-) early breast cancer (eBC). (journal article) Corda, Hugo \| Lasla, Hamza \| Guillerminet, Camille \| Lacombe, Marie \| Girault, Sylvie \| Campone, Mario \| Frenel, Jean-Sebastien \| Jézéquel, Pascal \| Patsouris, Anne Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e12567-e12567 (2024). 10.1200/JCO.2024.42.16_suppl.e12567 Cite \| Source
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study (journal article) Zhou, Ke \| Robert, Marie \| Seegers, Valérie \| Blanc-Lapierre, Audrey \| Savouroux, Stéphane \| Bigot, Frédéric \| Frenel, Jean-Sébastien \| Campone, Mario \| Conroy, Thierry \| Penault-Llorca, Frédérique \| ... \| Bellanger, Martine M. PLOS ONE, volume 19, issue 5, pages e0304556- (2024). 10.1371/journal.pone.0304556 Cite \| Source
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype (journal article) Jézéquel, Pascal \| Lasla, Hamza \| Gouraud, Wilfried \| Basseville, Agnès \| Michel, Bertrand \| Frenel, Jean-Sébastien \| Juin, Philippe P. \| Ben Azzouz, Fadoua \| Campone, Mario Breast Cancer (2024). 10.1007/s12282-024-01597-z Cite \| Source
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer (journal article) Goetz, Matthew P. \| Hamilton, Erika P. \| Campone, Mario \| Hurvitz, Sara A. \| Cortes, Javier \| Johnston, Stephen \| Llombart-Cussac, Antonio \| Kaufman, Peter A. \| Toi, Masakazu \| Jerusalem, Guy \| ... \| Martin, Miguel Clinical Cancer Research, volume 30, issue 10, pages 2233-2244 (2024). 10.1158/1078-0432.CCR-22-3573 Cited by (3) \| Cite \| Source
258P Real-world (rw) outcomes in patients (pts) with hormone receptor-positive and human epidermal growth factor receptor-2-negative (HR+/HER2-) metastatic breast cancer (mBC) treated with chemotherapy (CT) in France (journal article) Campone, M. \| Frenel, J-S. \| Kiver, V.I.I. \| Woeckel, A. \| Kerscher, A.G. \| Krebs, M. \| Leal, C.S. \| Saglimbene, V.M. \| Rehnquist, M.K. \| Sadetsky, N. \| ... \| Bocquet, F. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103279 Cite \| Source
132P Clinico-pathological characteristics, treatments and survival outcomes of patients with high-risk hormone receptor positive early breast cancer (HR+ BC) in French real-world (RW) setting: A study from CANTO cohort (journal article) Giugliano, F. \| Bertaut, A. \| Blanc, J. \| Martin, A-L. \| Gaudin, C. \| Fournier, M. \| Kieffer, A. \| Sauterey, B. \| Levy, C. \| Campone, M. \| ... \| Rassy, E. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103119 Cite \| Source
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials (journal article) Rugo, Hope S. \| Van Poznak, Catherine H. \| Neven, Patrick \| Danielewicz, Iwona \| Lee, Soo Chin \| Campone, Mario \| Chik, Jeannie Y. K. \| Vega Alonso, Estela \| Naume, Bjørn \| Brain, Etienne \| ... \| Coleman, Robert E. Breast Cancer Research and Treatment, volume 204, issue 2, pages 249-259 (2024). 10.1007/s10549-023-07147-z Cited by (2) \| Cite \| Source
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane (journal article) Vanacker, Hélène \| Treilleux, Isabelle \| Schiffler, Camille \| Bieche, Ivan \| Campone, Mario \| Patsouris, Anne \| Arnedos, Monica \| Cottu, Paul H. \| Jacquin, Jean-Philippe \| Dalenc, Florence \| ... \| Bachelot, Thomas British Journal of Cancer, volume 130, issue 4, pages 613-619 (2024). 10.1038/s41416-023-02549-8 Cite \| Source
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer (journal article) Campone, Mario \| Bidard, François-Clément \| Neven, Patrick \| Wang, Lei \| Ling, Bin \| Dong, Yvonne \| Paux, Gautier \| Herold, Christina \| De Giorgi, Ugo Breast Cancer Research, volume 25, issue 1 (2023). 10.1186/s13058-023-01740-2 Cited by (1) \| Cite \| Source
73TiP Global phase III studies evaluating vepdegestrant in estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: VERITAC-2 and VERITAC-3 (journal article) Iwata, H. \| Hamilton, E.P. \| Ma, C.X. \| De Laurentiis, M. \| Hurvitz, S.A. \| Wander, S.A. \| Danso, M.A. \| Lu, D.R. \| Perkins, J. \| Liu, Y. \| ... \| Campone, M. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.10.207 Cite \| Source
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial (journal article) Kessler, Tobias \| Schrimpf, Daniel \| Doerner, Laura \| Hai, Ling \| Kaulen, Leon D. \| Ito, Jakob \| van den Bent, Martin \| Taphoorn, Martin \| Brandes, Alba A. \| Idbaih, Ahmed \| ... \| Wick, Antje Clinical Cancer Research, volume 29, issue 19, pages 3892-3900 (2023). 10.1158/1078-0432.CCR-23-0926 Cited by (6) \| Cite \| Source
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) (journal article) Seegers, Valérie \| Rousseau, Guillaume \| Zhou, Ke \| Blanc-Lapierre, Audrey \| Bigot, Frédéric \| Mahammedi, Hakim \| Lambert, Aurélien \| Moreau-Bachelard, Camille \| Campone, Mario \| Conroy, Thierry \| ... \| Raoul, Jean-Luc Cancers, volume 15, issue 19, pages 4777- (2023). 10.3390/cancers15194777 Cited by (1) \| Cite \| Source
P05.01.B PROGNOSTIC MARKERS OF DNA METHYLATION AND NGS SEQUENCING IN PROGRESSIVE GLIOBLASTOMA FROM THE EORTC-26101 TRIAL (journal article) Kessler, T \| Schrimpf, D \| Doerner, L \| Hai, L \| Kaulen, L \| Ito, J \| van den Bent, M \| Taphoorn, M \| Brandes, A A \| Idbaih, A \| ... \| Wick, A Neuro-Oncology, volume 25, issue Supplement_2, pages ii43-ii43 (2023). 10.1093/neuonc/noad137.138 Cite \| Source
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer (journal article) Tolaney, Sara M. \| Chan, Arlene \| Petrakova, Katarina \| Delaloge, Suzette \| Campone, Mario \| Iwata, Hiroji \| Peddi, Parvin F. \| Kaufman, Peter A. \| De Kermadec, Elisabeth \| Liu, Qianying \| ... \| Im, Seock-Ah Journal of Clinical Oncology, volume 41, issue 24, pages 4014-4024 (2023). 10.1200/JCO.22.02746 Cited by (22) \| Cite \| Source
Evaluating everolimus for the treatment of breast cancer (journal article) Moreau-Bachelard, Camille \| Robert, Marie \| Gourmelon, Carole \| Bourbouloux, Emmanuelle \| Patsouris, Anne \| Frenel, Jean-Sébastien \| Campone, Mario Expert Opinion on Pharmacotherapy, volume 24, issue 10, pages 1105-1111 (2023). 10.1080/14656566.2023.2214677 Cited by (7) \| Cite \| Source
VERITAC-2: A global, randomized phase 3 study of ARV-471, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, vs fulvestrant in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer. (journal article) Campone, Mario \| Ma, Cynthia X. \| De Laurentiis, Michelino \| Iwata, Hiroji \| Hurvitz, Sara A. \| Wander, Seth Andrew \| Danso, Michael A. \| Lu, Dongrui Ray \| Perkins Smith, Julia \| Liu, Yuan \| ... \| Hamilton, Erika P. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages TPS1122-TPS1122 (2023). 10.1200/JCO.2023.41.16_suppl.TPS1122 Cited by (13) \| Cite \| Source
257TiP VERITAC-2: A global, randomized phase III study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, vs fulvestrant in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer (journal article) Hamilton, E. \| Ma, C.X. \| De Laurentiis, M. \| Iwata, H. \| Hurvitz, S.A. \| Wander, S.A. \| Danso, M.A. \| Lu, D.R. \| Perkins, J. \| Liu, Y. \| ... \| Campone, M. ESMO Open, volume 8, issue 1, pages 101445- (2023). 10.1016/j.esmoop.2023.101445 Cited by (1) \| Cite \| Source
206P Capivasertib (C) + palbociclib (P) and fulvestrant (F) in patients (pts) with HR+/HER2- advanced breast cancer (ABC): Phase Ib data from CAPItello-292 (journal article) Neven, P. \| Hamilton, E. \| Pistilli, B. \| Borges, V. \| Campone, M. \| Foukakis, T. \| Kodahl, A. Raskov \| Lau, P.K.H. \| Lim, E. \| Lugowska, I. \| ... \| Rugo, H.S. ESMO Open, volume 8, issue 1, pages 101395- (2023). 10.1016/j.esmoop.2023.101395 Cited by (1) \| Cite \| Source
Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers (journal article) Bocquet, François \| Raimbourg, Judith \| Bigot, Frédéric \| Simmet, Victor \| Campone, Mario \| Frenel, Jean-Sébastien International Journal of Environmental Research and Public Health, volume 20, issue 2, pages 1645- (2023). 10.3390/ijerph20021645 Cited by (1) \| Cite \| Source